A carregar...
Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
BACKGROUND: Formoterol fumarate inhalation solution (FFIS; Perforomist(®)) is a long-acting β(2)-agonist (LABA) marketed in the US as a nebulized COPD maintenance treatment. Because long-term LABA use was associated with a potential increased risk of exacerbation or death in asthma patients, the US...
Na minha lista:
| Publicado no: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6311322/ https://ncbi.nlm.nih.gov/pubmed/30643398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S173595 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|